Market Cap (In USD)
7835.00
Revenue (In USD)
1.82 Million
Net Income (In USD)
-3.67 Million
Avg. Volume
96.00
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 1.7E-4-2.28
- PE
- -
- EPS
- -
- Beta Value
- 0.07
- ISIN
- FR0010120402
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Mr. Martin Deterre
- Employee Count
- -
- Website
- https://www.theraclion.com
- Ipo Date
- 2019-04-22
- Details
- Theraclion SA develops echotherapy solutions using high intensity focused ultrasound system. It offers SONOVEIN, a robotic solution for non-invasive echotherapy treatment of varicose veins; ECHOPULSE, a robotic and non-invasive solution for echotherapy treatment of thyroid nodules and breast fibroadenoma; and EPack, a disposable that is installed on the device before treatment and protects the patient's skin and optimizes the image quality. The company was founded in 2004 and is based in Malakoff, France.
More Stocks
-
JBGSJBG SMITH Properties
JBGS
-
3699
-
9520
-
CHDCHEMChd Chemicals Limited
CHDCHEM
-
OSUKFOtsuka Corporation
OSUKF
-
600193
-
8171
-
WWSG